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Abstract
Introduction: Selected IgA deficiency (IgAD) and common variable immune deficiency (CVID) are humoral immunity deficien-
cies frequent in children. In both these types of immunodeficiency, autoimmune diseases are present in 20–30% of patients, but 
the disease profiles are different between adults and children. Autoimmune diseases of the gastrointestinal tract (IBD) and celiac 
disease are typical for children with IgAD and CVID. Diagnosis is based on clinical symptoms, histology of jejunum and antibodies 
often preceding the onset of disease. However, the diagnosis of IBD and celiac disease is difficult in immune deficiency patients 
due to weaker or absent production of antibodies, and different jejunum histology, particular in CVID patients. 
Aim: Detection of antibodies for autoimmune diseases in children with diagnosis of CVID and IgAD.
Material and methods: The study included 43 children with CVID and 63 children with IgAD diagnosis. Antibodies typical for 
celiac disease (for endomysium, tissue transglutaminase and gliadin) were tested in IgA class (CVID patients), IgG class (IgAD, 
CVID patients) and found in 16 patients (3 – CVID, 13 – IgAD). 
Results: Antibodies for IBD (for Saccharomyces cerevisiae antigen – ASCA, goblet cells – Gab, neutrophil’s cytoplasm – ANCA, 
pancreatic cells – Pab) were noted in 17 patients (7 – CVID, 10 – IgAD). Celiac disease was diagnosed in two children with mild 
and unspecific clinical symptoms followed by introduction of a gluten-free diet. The remaining children with present antibodies 
but without clinical symptoms involving the gastrointestinal tract are under careful clinical observation with antibody assay 
every 6 months. 
Conclusions: The antibodies are produced despite impaired humoral immunity but the level might be low so the lower limit 
of positive results is postulated.
Introduction
The association between autoimmunity and humor-
al immune deficiency is well known [1–3], although the 
mechanisms of autoimmune diseases associated with 
primary immune deficiency are not fully described [3–5]. 
Autoimmune diseases are the most frequent in com-
mon variable immune deficiency (CVID) and selected 
IgA deficiency (IgAD) [6–14]. 
The diagnosis of CVID is based on a significantly 
reduced level of IgG and/or IgA and IgM, accompa-
nied by impaired or absent production of specific an-
tibodies. The disturbances in cellular immunity include 
a decrease of lymphocyte number, weak response to 
mitogens and antigens, and reduced production of cy-
tokines. The common clinical symptoms of CVID are 
recurrent bacterial infections, mainly involving the re-
spiratory tract, with a poor response to antibiotic ther-
apy and prolonged course [1, 7, 9]. Chronic sinusitis and 
bronchiectasis are frequent in older children and adults 
after years of CVID independently of regular immuno-
globulin substitution in a prophylactic dose [9].
The wide range of clinical features associated with 
CVID includes gastrointestinal symptoms. Depending on 
the studied group, gastrointestinal (GI) involvement was 
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noted in 20% up to 60% of CVID patients [2, 9, 15, 16]. 
It is believed that in children with CVID, the gastrointes-
tinal symptoms lead to underweight and inhibition of 
growth followed by jejunal dysfunction and malabsorp-
tion. However, as the symptoms overlap, the decreased 
weight and inhibition of growth might be explained by 
frequent infections, chronic inflammation and different 
therapies used during infections. The occurrence of au-
toimmune diseases in CVID is very common, but the 
profile of autoimmune diseases differs between chil-
dren and adults. Gastrointestinal diseases, e.g. celiac 
disease or Crohn’s disease, are more often noted in 
CVID and IgAD patients diagnosed in childhood than 
in those diagnosed later in life. Moreover, the clinical 
symptoms and the histology of jejunum biopsy from 
children with CVID showed characteristic differences 
as compared to children without immune deficiency 
[17]. In histology, the lack of plasma cells is typical and 
most striking. The increase of number of intraepitheli-
al lymphocytes (IEL), granulomas and crypt distortion 
are characteristic and often mimic other features, e.g. 
graft-versus host disease [2, 15]. These differences have 
led to inflammatory GI diseases in CVID patients being 
named as “sprue-like”, “celiac-like” and “Crohn’s-like” 
[2]. In children with the diagnosis of CVID but preserved 
production of IgA (tested in the serum as representative 
for secretory IgA produced in the jejunum), the infiltra-
tions and production of autoantibodies within infil-
trates under the mucous membrane are similar to those 
seen in children without CVID, which stresses the role 
of secretory IgA for gastrointestinal tract function [2]. 
Patients with IgAD have an increased risk of or-
gan-specific autoimmune disease, e.g. diabetes melli-
tus type 1, autoimmune thyroiditis and celiac disease. 
The prevalence of celiac disease in IgAD patients is 
about 3%, which represents a 10–16-fold increase as 
compared to the general population [2, 4]. The clinical 
symptoms are often unspecific, suggesting a late-on-
set, hidden or asymptomatic form of celiac disease. In 
children without immune deficiency, the immunological 
detection of celiac disease based on autoantibodies and 
IgA class antibodies in the serum is clinically valuable as 
a screening test. In CVID and IgAD patients, the results 
of tests based on IgA may be false negative and the 
results of tests based on IgG should be considered as 
valuable and clinically significant [2, 18, 19].
The problem of antibody production in CVID is more 
complex, since we know that the regular intravenous sub-
stitution of IgG, even in prophylactic doses, might be sup-
pressive for own production of immunoglobulin including 
specific antibodies [20]. However, this suppression seems 
to be weak and the situation of permanent stimulation 
of the immune system with present antigens or autoanti-
gens may overcome this suppression. The common view 
that in CVID the production of specific antibodies is low 
or absent was based on assays of response to vaccines 
or bacterial antigens from infections presented to the im-
mune system in single doses [1, 9]. The prolonged expo-
sure of immune-competent cells to antigens in unknown; 
long duration of the ongoing autoimmune process in sub-
clinical forms is a possible explanation for autoantibody 
production by humoral immune deficiency patients. 
In inflammatory diseases of the GI, e.g. Crohn’s dis-
ease or ulcerative colitis, the increase of mucous mem-
brane permeability for bacterial and yeast antigens in-
duces uncontrolled migration of various antigens through 
the membrane followed by contact with lymphoid tis-
sues. In consequence, the process of inflammation be-
gins and is continued supported by increasing infiltra-
tion of immuno-competent cells, local production of 
proinflammatory cytokines and induction of a humoral 
response [2, 15, 21]. The permanent stimulation is prob-
ably sufficient to stimulate the immune system for the 
production of different types of antibodies, including au-
toantibodies, even in CVID patients. It is the rationale for 
detection of antibodies in the serum of CVID patients. 
However, in these patients, there is a possibility that the 
antibodies may be seen not in all individuals despite the 
ongoing autoimmune process. In patients with low pro-
duction of antibodies (below detection or border level) 
and subclinical course, autoimmune gastrointestinal dis-
eases are undiagnosed or delayed in diagnosis until more 
specific symptoms occur and/or antibody levels increase. 
In IgAD patients, the production of antibodies is pos-
sible only in IgG class and tests using IgG are preferred 
for the diagnosis of autoimmune disease. Moreover, 
there is no immunoglobulin substitution in these chil-
dren, so the results in IgG class are valuable and clinical-
ly significant. The possibility of detection of antibodies 
helps to diagnose autoimmune diseases in IgAD patients 
reasonably early. The clinical significance of early diag-
nosis is obvious, especially when the therapy, e.g. in 
celiac disease, is a gluten-free diet (GFD) and may be 
introduced immediately. However, observations of CVID 
patients with celiac disease showed lack of effectiveness 
of GFD recognized as refractory celiac disease (RCD) with 
progression of malabsorption syndrome in individual pa-
tients [22]. It indicates that autoimmune and/or chronic 
inflammatory processes are different in immune defi-
ciency patients and the standard therapy may fail.
Aim
The purpose of the study was to show the useful-
ness of serological tests for celiac disease and IBD as 
screening and diagnostic procedures in patients with 
IgAD and CVID.
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Material and methods
Patients
One hundred and six children (37 girls, 69 boys, 
aged 1-18 years) with the diagnosis of humoral immune 
deficiency were included in the study. Based on the di-
agnosis, the following groups were described:
Group I: 43 children (12 girls, 31 boys, mean age – 
9 years) – 37 patients with CVID, 5 patients with hy-
pogammaglobulinemia and 1 patient with lack of spe-
cific antibody synthesis. Patients from this group are on 
regular substitution of immunoglobulins (mean time – 
3 years, 2 months); 
Group II: 63 patients (25 girls, 38 boys, mean age – 
7 years, 11 months) with the diagnosis of isolated IgA 
deficiency (IgAD). 
Infections and other diseases in children
with IgA deficiency and common 
variable immune deficiency
In group I (43 patients), more than half of patients 
showed recurrent respiratory tract infections despite 
regular substitution of immunoglobulins. Hematologi-
cal disorders included chronic thrombocytopenia (3 pa-
tients) and leukopenia (4 patients). In one girl, celiac 
disease had been diagnosed before this study with 
improvement (no clinical symptom or antibody pro-
duction) on GFD. Six patients demonstrated allergy 
(4 – bronchial asthma, 2 – allergic rhinitis). Two patients 
with CVID had been diagnosed with autism before the 
diagnosis of CVID was established; another patient is 
being monitored by a cardiologist because of cardio-
myopathy diagnosed in infancy. In the course of CVID, 
in one girl, the diagnosis of lymphocytic infiltrating 
pneumonia (LIP) was established followed with steroid 
therapy. In group II, infections of the upper respiratory 
tract were noted in 63% of the patients. Two patients 
had been diagnosed with celiac disease, six with bron-
chial asthma and 8 with allergic rhinitis and food allergy 
before this study. One patient had been diagnosed with 
diabetes type 1, now treated with insulin. One boy is on 
regular therapy against epilepsy (Table I). 
Methods
In all the patients, detection of antibodies typical for 
inflammatory bowel diseases (IBD), celiac disease (CD) 
and atrophic gastritis (AG) was performed qualitatively 
with indirect immunofluorescence (IIF) and quantita-
tive ELISA techniques. Standard kits from Euroimmun 
(Lubeck, Germany) were used containing the following 
tissue slides: pancreas, jejunum, stomach, esopha-
gus, neutrophils and drops of gliadin extract (FA 1380, 
FA 1919, FA 1911). Additionally, screening tests for sys-
temic autoimmune disease antibodies were performed 
with IIF (FA 1800-2005-6). The slides were assayed 
with a fluorescence microscope (Bx60, Olympus, Japan) 
under 100× magnification by two independent investi-
gators. Highly purified antigens of Saccharomyces cer-
evisiae cell membrane (EV 2841-9601), enzyme tissue 
transglutaminase (EA 1910-9610) and parietal cell an-
tigens (EV 1361-9610) (Euroimmun) were used in ELISA 
technique. The control sera (positive and negative) were 
run in parallel to patients’ sera.
Antibodies for celiac disease:
–  anti-endomysial antibodies (EmA) with IIF. Positive 
results are seen as linear fluorescence of reticulin 
present in smooth muscles and jejunum villi slides in 
patients’ serum diluted 1 : 10;
Table I. Characteristics of patients included in the study (group I and II)
Clinical symptoms Group I
CVID; 43 patients
Group II
IgAD; 63 patients
Infections of respiratory tract 25 40
Thrombocytopenia 3 0
Leukopenia 4 0
Celiac disease (diagnosed before study) 1 2
Bronchitis asthma 4 6
Allergy (atopic dermatitis, food allergy) 2 8
Autism 2 0
Cardiomyopathy (diagnosed at age 6 months) 1 0
Lymphocytic infiltrating pneumonia (LIP) 1 0
Diabetes type 1 0 1
Epilepsy 0 1
Regular immunoglobulin substitution 1–9 years (mean – 3.64 years) no
Przegląd Gastroenterologiczny 2013; 8 (6)
373
Occurrence of autoantibodies for gastrointestinal autoimmune diseases in children with common variable immune deficiency  
and selected IgA deficiency
–  anti-gliadin antibodies – (AGA) with IIF. Positive re-
sults are seen as fluorescence of purified gliadin drop-
lets in the serum diluted 1 : 10;
–  anti-tissue transglutaminase enzyme (tTGA) with ELISA 
kit. The dilution of the serum 1 : 100, positive results – 
absorbance above 20 RU/ml according to the standard 
curve in IgA and IgG class according to the manufactur-
er’s instructions. All the above tests were performed in 
IgA class and IgG class for studied patients.
Antibodies for Crohn’s disease:
–  anti-Saccharomyces cerevisiae antibodies (ASCA) with 
ELISA. Positive results – absorbance above 20 RU/ml 
according to the standard curve in the serum diluted 
1 : 100 in IgA and IgG class;
–  anti-exocrine pancreatic cells and their products (Pab) 
with IIF. Positive results are seen as bright fluores-
cence of pancreatic cell cytoplasm and droplets of pro-
duced enzymes in the serum diluted 1 : 10.
Antibodies for ulcerative colitis:
–  antibodies for neutrophil cytoplasm antigens (ANCA) 
with IIF seen on human neutrophil slides. Positive re-
sults are seen as granular fluorescence within cyto-
plasm (atypical ANCA – aANCA) or linear perinuclear 
pattern (pANCA) in the serum diluted 1 : 10;
–  antibodies for goblet cells (Gab) with IIF. Positive results 
are seen as bright fluorescence of goblet cell cytoplasm 
(mucins are an antigen) in the serum diluted 1 : 10.
Antibodies for atrophic gastritis:
–  antibodies for parietal cells (PCA) with ELISA. Absor-
bance higher than 20 RU/ml according to the stan-
dard curve is considered as positive in the serum di-
luted 1 : 100 [14].
Antibodies for systemic autoimmune disease (scre-
ening):
–  for nuclear antigens (ANA), for smooth muscles (SMA), 
mitochondrial (AMA) and liver-kidney microsomal an-
tigen (LKMS) with IIF in the serum diluted 1 : 100. The 
fluorescence of the patient’s serum was compared to 
positive and negative controls.
Because of immune deficiency the limit of positive 
results for antibody presence in serum tested with 
ELISA was lowered to 10 RU/ml for CVID patients and 
routinely performed in IgG class for IgAD and CVID 
(without IgA) patients. 
Results
Frequency and type of antibodies 
 for autoimmune diseases  
of gastrointestinal tract 
In the analyzed group of 106 patients, antibodies 
typical for IBD were noted in 17 patients (16.0%). The 
types of antibodies were as follows: for ASCA in IgG 
class – 11 patients, IgA and IgG class – 2 patients and 
IgA class only – 1 patient, ANCA – 2 patients and Gab – 
1 patient. 
Antibodies for celiac disease were noted in 16 pa-
tients (15.0%) – AGA – 10 patients, tTG – 3 patients 
(in 2 cases together with EmA) and EmA (in IgG class) 
in 3 patients. PCA were seen in the sera of 5 patients 
(4.71%) (Table II). 
The relation of antibodies to type 
of immune deficiency
Group I (43 patients)
Antibodies for IBD were noted in 7 patients 
(16.27%): ASCA in IgG class – 4 patients, ASCA in both 
IgG and IgA class – 2 patients, and ASCA in IgA class – 
1 patient. Antibodies typical for celiac disease were not-
ed in 3 patients (6.9%) – EmA in IgA class together with 
tTG and AGA in 2 patients, followed by clinical and his-
tological diagnosis of celiac disease. Additionally, AGA in 
IgG class were seen in one patient’s serum.
Group II (63 patients)
Antibodies for IBD were noted in 10 patients 
(15.87%): ASCA in IgG class – 7 patients, ANCA – 2 pa-
tients, and Gab – 1 patient. Antibodies typical for ce-
liac disease were found 13 patients (20.6%) – AGA in 
9 pa tients, tTG (in IgA and IgG class) in 1 patient (now 
under diagnostic procedure of celiac disease) and EmA 
in 3 pa tients.
The frequency and type of antibodies in relation to 
diagnosis are shown in Table II.
Clinical symptoms in patients with IgA 
deficiency and common variable immune 
deficiency and present antibodies
All the patients with present antibodies were exam-
ined for IBD and celiac disease according to standard 
procedures. In group I, clinical gastrointestinal tract 
symptoms were found in 3 patients, including two with 
newly diagnosed celiac disease. These symptoms were 
mild and unspecific, e.g. underweight and low gain of 
weight, feeling of discomfort after meals. In both celiac 
patients, the clinical course was different than in chil-
dren without immune deficiency. The first patient with 
mild GI symptoms without changes in jejunum histology 
(Marsh 0) improved on GFD. The second celiac patient 
demonstrated a high level of tTG antibodies for more 
than one year of observation despite restricted GFD. 
Moreover, what seems to be interesting is the pres-
ence of PCA in children with IgAD and CVID without 
clinical and histological symptoms of an autoimmune 
process.
In both groups (IgAD and CVID), there were patients 
without antibodies, but with some mild gastrointestinal 
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tract symptoms: 5 patients in group I, and 4 patients in 
group II. These children are being monitored very care-
fully.
Autoantibodies for systemic autoimmune
diseases 
In group I, ANA were detected in 5 patients, and 
SMA in 3 patients. In group II, ANA were found in 5 pa-
tients (Table II). These antibodies were considered as 
markers of possible autoimmune phenomena only. A re-
test is suggested every 6 months if clinical symptoms 
do not occur.
Conclusions
In children with CVID and IgAD, detection of auto-
antibodies every 4–6 months is required to select pa-
tients at high risk of autoimmune diseases, especially 
involving the gastrointestinal tract. Autoantibodies for 
autoimmune diseases were noted in about half of chil-
dren with CVID and IgAD, without any typical clinical 
symptoms of the diseases in the majority of them. In 
children without clinical symptoms, but with antibod-
ies present for 1 year or more, diagnostic procedures 
including gastroscopy, colonoscopy and biopsy are indi-
cated to diagnose IBD or celiac disease in a subclinical 
form. The detailed analysis of jejunum histology includ-
ing atypical features is suggested.
Discussion
The precise and sensitive methods of detection of 
various antibodies have shown the possibility of sero-
logic screening and supporting the diagnosis of autoim-
mune disease in patients with immune deficiency, e.g. 
CVID and IgAD. Moreover, regular substitution of IgG in 
CVID patients is not suppressive enough to inhibit the 
autoantibody production below the level of detection 
in the serum. 
In our study, the antibodies were noted in almost 
half of the patients with the diagnosis of IgAD and CVID. 
In CVID, antibodies for IBD and celiac disease were pres-
ent in 23% of patients with the presence of ASCA, which 
suggests the possibility of development of Crohn’s dis-
ease. In IgAD, antibodies for celiac disease were noted 
in 20% of the patients, which supported observations 
of increased risk of this disease in IgAD. Moreover, due 
to the possibility of ongoing celiac disease in latent, 
asymptomatic form, clinical and laboratory diagnostic 
procedures are indicated as the subsequent steps with-
out any undue time loss [19, 23]. All these patients were 
without typical clinical symptoms suggestive of a particu-
lar inflammatory disease. Only two patients showed mild 
gastrointestinal symptoms and celiac disease was diag-
nosed by biopsy in one of them; in the second case, his-
tology showed no typical changes (grade 0 according to 
the Marsh scale). The GFD was introduced in both cases 
with improvement of patients (e.g. increase of weight). 
The remaining patients positive for IBD or celiac disease 
antibodies are being monitored (the antibody panel is 
tested every 6 months). Clinical follow-up is careful; all 
symptoms, even mild, are noted and analyzed in detail.
In children with isolated IgAD, celiac disease is the 
most common as an autoimmune association. The de-
Table II. Occurrence of antibodies typical for gastrointestinal autoimmune diseases (celiac disease and IBD)  
in CVID and IgAD patients included in the study
Antibodies for: Group I
CVID (n = 43)
Group II
IgAD (n = 63)
All patients
(n = 106) 
Total 
IBD ASCA (IgG) 4 7 11
17 (16.0%)
ASCA (IgG + IgA) 2 0 2
ASCA (IgA) 1 0 1
ANCA 0 2 2
Gab 0 1 1
Celiac disease tTG + EmA + AGA 2 1 3
16 (15.09%)EmA 0 3 3
AGA 1 9 10
Atrophic gastritis PCA 2 3 5 5 (4.71%)
Systemic
autoimmune diseases
ANA 5 5 10 10 (9.43%)
SMA 3 0 3 3 (3.44%)
Total 20 (46.5%) 31 (47.61%) 51 (48.11%)
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tection of antibodies in IgG class is used for screening, 
initial diagnosis and monitoring during GFD. In these 
patients, antibodies in class IgG are clinically signifi-
cant as compared to antibodies in IgA class in patients 
without IgAD [2, 23]. In adults with IgAD, systemic lu-
pus erythematosus (SLE) is frequently observed and 
antinuclear antibodies are used for diagnosis, similarly 
as in patients with normal IgA production. In children, 
ANA are considered a signal of a possible process and 
monitored only, as SLE is rare in children with IgAD [12, 
13]. The presence of ANA is an indication for prolonged 
observation only without the possibility of predicting 
the development of clinical symptoms of disease [14]. 
The diagnosis of autoimmune diseases in patients 
with immune deficiency is problematic for two reasons: 
one of them is the low production of antibodies in case 
of a decreased number of B lymphocytes and the pres-
ence of antibodies without clinical symptoms of dis-
ease; and the second is the possible suppressive effect 
of regular substitution of IgG (e.g. in CVID). These two 
phenomena may lead to low levels of autoantibodies 
detected in the serum. Considering these two aspects 
of antibody detection in patients with humoral immune 
deficiency, modification of interpretation of the anti-
body detection results seems to be a reasonable solu-
tion. The decrease of the lower limit for positive results 
is the basic modification, so the antibodies present in 
lower titer are accepted as valuable and clinically signif-
icant. However, in single observation the level of ANA 
before and after intravenous infusions of immunoglob-
ulins (0.4 g/kg b.w. dose) was unchanged, which sug-
gested that the induced production of autoantibodies is 
strong enough to be preserved despite immunoglobulin 
substitution. It may be speculated that this suppres-
sive effect of immunoglobulin in a low dose prevents 
the occurrence of autoantibody production but is too 
weak when this process was induced. The autoanti-
bodies are involved in reactions with antigens (auto-
antigens) present in the tissue of the target organ for 
this autoimmune process. In the serum, the circulating 
antibodies are seen when the production is higher than 
uptake by the tissue. In the case of low production and 
an ongoing process of reaction with antigens, the level 
of antibodies in the serum is below the detection lev-
el. This explains cases when an autoimmune process is 
seen e.g. in the histology of the affected tissue/organ, 
but the circulating antibodies are absent in the serum. 
In children with immune deficiency, this possibility is 
important because the lack of antibodies does not ex-
clude the autoimmune process leading to tissue dam-
age. The opposite situation is noted when the antibod-
ies are present without any clinical symptoms, in which 
case they may be considered as markers of an ongoing 
autoimmune process in subclinical form. These patients 
are under long-term observation with regular checking 
of antibodies and occurrence of clinical symptoms. The 
presence of antibodies is often observed as a phenom-
enon preceding the autoimmune process and onset of 
clinical symptoms. Moreover, in these patients, the dif-
ferential diagnostic procedures include a wide range of 
tests and methods, e.g. for bacterial overgrowth in the 
jejunum, bacterial characteristics of the stool, presence 
of parasites (e.g. Giardia lamblia), and parameters sug-
gesting malabsorption (e.g. iron level, aphthae, osteo-
penia), to prove or exclude the autoimmune disease. 
The course, symptoms and histology of autoimmune 
diseases in immune deficient patients are different as 
compared to the characteristics of similar diseases ob-
served in patients without immune deficiency. In adult 
patients with CVID, autoimmune gastritis, pernicious 
anemia, Crohn’s disease and ulcerative colitis are more 
frequent than in children. The differences of autoim-
mune diseases between healthy and immune deficient 
patients are seen in both aspects – clinical and labo-
ratory. Patients with immune deficiency often present 
scarce, unspecific clinical symptoms that overlap with 
the effects of frequent infections and chronic inflamma-
tory complications. In the histology of jejunum biopsy 
material, changed proportions of T lymphocyte subpop-
ulations (TCR a/b: TCR g/d) and an increased number 
of Tregs are noted [15]. Intraepithelial lymphocytosis, 
lymphoid aggregates, granulomas, crypt distortion and 
lack of plasma cells are characteristic. Moreover, in in-
flammatory bowel-like disease, the histological pattern 
of biopsy in CVID patients often mimics graft-versus-
host disease, lymphoid hyperplasia and villous atrophy 
that resembles celiac disease [13, 22].
The problem of low or lack of specific antibody se-
cretion in CVID is not as common as would be expected. 
The antibodies in IgA class are detected in a reasonable 
number of patients and the clinical significance of these 
antibodies is high. The problem is in patients without 
circulating antibodies, but in the case of clinical symp-
toms, biopsy is indicated because of its basic and high 
diagnostic value. 
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